L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 33-39

  Mytilineou, Catherine ^a   Radcliffe, Pheona ^a   Leonardi, Efthimia Kokotos ^a   Werner, Peter ^a   Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Deprenyl; Dopamine; Excitotoxicity; Glutamate; Neuroprotection; Parkinson's disease

Indexed keywords

DIZOCILPINE; GLUTAMATE RECEPTOR; MONOAMINE OXIDASE INHIBITOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PARGYLINE; SELEGILINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; EMBRYO; MESENCEPHALON; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0031020650     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010033.x     Document Type: Article

References (52)

1. Ansari K. S., Yu P. H., Kruck T. P. A., and Tatton W. G. (1993) Rescue of axotomized immature rat facial motoneurons by R(-)-L-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J. Neurosci. 13, 4042-4053.
2. Behl C., Hovey L., Krajewski S., Schubert D., and Reed J. C. (1993) BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Commun. 197, 949-956.
3. Biagini G., Frasoldati A., Fuxe K., and Agnati L. F. (1994) The concept of astrocyte-kinetic drug in the treatment of neurodegenerative disease: evidence for 1-deprenyl-induced activation of reactive astrocytes. Neurochem. Int. 25, 17-22.
4. Birkmayer W. and Riederer P. (1984) Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's disease. Adv. Neurol. 40, 475-481.
5. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S. A. (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA 92, 7162-7166.
6. Carillo M.-C., Kanai S., Sato Y., Ivy G. O., and Kitani K. (1992) Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during deprenyl infusion in male rats. Biochem. Pharmacol. 44, 2185-2189.
7. Carrillo M.-C., Ivy G. O., Milgram N. W., Head E., Wu P., and Kitani K. (1994a) (-)L-Deprenyl increases activities of superoxide dismutase (SOD) in striatum of dog brain. Life Sci. 54, 1483-1489.
8. Carrillo M.-C., Kitani K., Kanai S., Sato Y., Miyasaka K., and Ivy G. O. (1994b) (-)L-Deprenyl increases activities of superoxide dismutase and catalase in certain brain regions of old male mice. Life Sci. 54, 975-981.
9. Casper D. and Blum M. (1995) Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture. J. Neurochem. 65, 1016-1026.
10. Chiueh C. C., Huang S. J., and Murphy D. L. (1994) Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity. J. Neural Transm. Suppl. 41, 189-196.
11. Choi D. W., Maulucci-Gedde M., and Kriegstein A. R. (1987) Glutamate neurotoxicity in cortical cell cultures. J. Neurosci. 7, 357-368.
12. Cohen G. and Spina M. B. (1989) L-Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26, 689-690.
13. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate and neurodegenerative disorders. Science 262, 689-694.
14. Dawson T. M., Dawson V. L., and Snyder S. H. (1992) A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol. 32, 297-311.
15. Driscoll B. F., Law M. J., and Crane A. M. (1991) Cell damage associated with changing the medium of mesencephalic cultures in serum free medium is mediated via N-methyl-D-aspartate receptors. J. Neurochem. 56, 1201-1206.
16. Driscoll B. F., Deibler G. E., Law M. J., and Crane A. M. (1993) Damage to neurons in culture following medium change: role of glutamine and extracellular generation of glutamate. J. Neurochem. 61, 1795-1800.
17. Dumius A., Sebben M., Haynes L., Pin J.-P., and Bockaert J. (1988) NMDA receptors activate the arachidonic acid cascade in striatal neurons. Nature 336, 68-70.
18. Dykens J. A., Stern A., and Trenkner E. (1987) Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49, 1222-1228.
19. Frandsen A. and Schousboe A. (1993) Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons. J. Neurochem. 60, 1202-1211,
20. Golbe L. I., Lieberman A. N., Muenter M. D., Ahlskog J. E., Gopinathan G., Neophytides A., and Duvoisin R. C. (1988) Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease. Clin. Neuropharmacol. 11, 45-55.
21. +). J. Neurochem. 66, 74-82.
22. Kato K., Puttfarcken P. S., Lyons W. E., and Coyle J. T. (1991) Developmental time course and ionic dependence of kainate-mediated toxicity in rat cerebellar granule cell cultures. J. Pharmacol. Exp. Ther. 256, 402-411.
23. Knoll J. (1978) The possible mechanisms of action of (-)deprenyl in Parkinson's disease. J. Neural Transm. 43, 177-198.
24. Korsmeyer S. J., Yin S. M., Oltvai Z. N., Veis Novack D. J., and Linette G. P. (1995) Reactive oxygen species in the regulation of cell death by the bcl-2 gene family. Biochim. Biophys. Acta 1271, 63-66.
25. Krebs M.-O., Trovero F., Desban M., Gauchy C., Glowinski J., and Kernel M.-L. (1991) Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J. Neurosci. 11, 1256-1262.
26. Lafon-Cazal M., Pietri S., Culcasi M., and Bockaert J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
27. Marey-Semper I., Gelman M., and Levi-Strauss M. (1995) A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15, 5912-5918.
28. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
29. McCord J. (1985) Oxygen-derived free radicals in postischemic tissue injury. N. Engl. J. Med. 312, 159-163.
30. Mereu G., Costa E., Armstrong D. M., and Vicini S. (1991) Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J. Neurosci. 11, 1359-1366.
31. Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T., and Kagawa Y. (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 1450-1455.
32. +. J. Neurochem. 45, 1951-1953.
33. Mytilineou C., Han S.-K., and Cohen G. (1993) Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61, 1470-1478.
34. Olanow C. W. (1992) An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 32 (Suppl.), S2-S9.
35. Olanow C. W., Hauser R. A., Gauger L., Malapira T., Koller W., and Hubble J. (1995) The effect of deprenyl and levodopa on the progression of Parkinson's disease. Ann. Neurol. 38, 771-777.
36. Orrenius S., Burkitt M. J., Kass G. E. N., Dypbukt J. M., and Nicotera P. (1992) Calcium ions and oxidative cell injury. Ann. Neurol. 32 (Suppl.), S33-S42.
37. Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 321, 1364-1371.
38. Parkinson Study Group (1993) Effect of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328, 176-183.
39. Portera-Cailliau C., Hedreen J. C., Price D. L., and Koliatsos V. E. (1995) Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787.
40. Roy E. and Bedard P. J. (1993) L-Deprenyl increases survival of rat foetal nigral neurones in culture. Neuroreport 4, 1183-1186.
41. Salo P. T. and Tatton W. G. (1992) L-Deprenyl reduces the death of motoneurons caused by axotomy. J. Neurosci. Res. 31, 394-400.
42. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet i, 1269.
43. Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. K., Rosen B. R., and Beal M. F. (1995) Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64, 2239-2247.
44. Seniuk N. A., Henderson J. T., Tatton W. G., and Roder J. C. (1994) Increased CNTF gene expression in process-bearing astrocytes following injury is augmented by R(-)-deprenyl. J. Neurosci. Res. 37, 278-286.
45. 3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Eur. J. Pharmacol. 192, 19-24.
46. Spina M. B., Squinto S. P., Miller J., Lindsey R. M., and Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
47. Tatton W. G. and Greenwood C. E. (1991) Rescue of dying neurons: a new action for L-deprenyl in MPTP parkinsonism. J. Neurosci. Res. 30, 666-672.
48. Tatton W. G., Ju W. Y. L., Holland D. P., Tai C., and Kwan M. (1994) (-)-L-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J. Neurochem. 63, 1572-1575.
49. Tatton W. G., Ju W. Y. H., Wadia J., and Tatton N. A. (1996) Reduction of neuronal apoptosis by small molecules: promise for new approaches to neurological injury, in Neurodegeneration and Neuroprotection in Parkinson's Disease (Olanow C. W., Jenner P., and Youdim M., eds), pp. 209-220. Academic Press, London.
50. Thiffault C., Aumont N., Quirion R., and Poirier J. (1995) Effect of MPTP and L-deprenyl on antioxidant enzymes and lipid peroxidation levels in mouse brain. J. Neurochem. 65, 2725-2733.
51. van Lockeren Campagne M., Lucassen P. J., Vermeulen J. P., and Balázs R. (1995) NMDA and kainate induce internucleosomal cleavage associated with both apoptotic and necrotic cell death in the neonatal rat brain. Eur. J. Neurosci. 7, 1627-1640.
52. + in vivo. Eur. J. Pharmacol. 243, 241-247.